Stockscreener 앱 받기
4.01
3.08%
0.12
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Published on: 2026-03-26 07:22:01 - baoquankhu1.vn
Momentum Shift: Does TriSalus Life Sciences Inc have pricing power2026 Top Gainers & Technical Confirmation Alerts - baoquankhu1.vn
What is Northland Securities' Estimate for TLSI Q1 Earnings? - MarketBeat
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - Defense World
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - Defense World
Weekly Earnings: Can TriSalus Life Sciences Inc Equity Warrant keep up with sector leadersMarket Risk Analysis & Fast Exit and Entry Trade Guides - baoquankhu1.vn
TriSalus Life Sciences launches proposed public stock offering - MSN
Aug Movers: Is TriSalus Life Sciences Inc Equity Warrant a top pick in the sector2026 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
RSI Check: Is TriSalus Life Sciences Inc Equity Warrant forming a bullish divergenceMarket Volume Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Top TriSalus Executives Make Major Moves With Insider Stock Sales - TipRanks
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - MarketBeat
Szela, CEO of TriSalus, sells $79k in TLSI stock By Investing.com - Investing.com India
Szela, CEO of TriSalus, sells $79k in TLSI stock - Investing.com
TriSalus Life Sciences (TLSI) chief regulatory officer sells $14509 in stock - Investing.com
Devlin Jodi, TriSalus Life Sciences chief, sells $13k in TLSI stock - Investing.com Canada
Trisalus Life Sciences’ CCO Marshak sells $14k in TLSI stock - Investing.com India
TriSalus Life Sciences chief of research Cox sells $13k in TLSI stock - Investing.com
TriSalus (TLSI) executive sells 3,207 shares to satisfy RSU tax withholding - Stock Titan
TriSalus (TLSI) Chief of Research has 3,184 shares sold for tax withholding - Stock Titan
TriSalus (TLSI) CCO logs small tax-related share disposals, retains over 110K shares - Stock Titan
TriSalus Life Sciences (TLSI) CRO sells shares for taxes - Stock Titan
TriSalus (TLSI) CEO Szela disposes 20,302 shares for tax withholding - Stock Titan
TriSalus publishes preclinical data on drug delivery technology By Investing.com - Investing.com South Africa
Should I invest in TriSalus Life Sciences Inc before earningsWall Street Watch & Technical Buy Zone Confirmations - baoquankhu1.vn
TriSalus publishes preclinical data on drug delivery technology - Investing.com
Animal study from TriSalus pumps more immune drug into liver tumors in models - Stock Titan
Update Recap: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
Published on: 2026-03-18 18:04:21 - baoquankhu1.vn
Analysis Recap: Is TriSalus Life Sciences Inc Equity Warrant benefiting from innovation trends2026 Key Lessons & Capital Efficiency Focused Ideas - baoquankhu1.vn
Canaccord lowers its price target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and maintains a buy rating - MSN
Canaccord Lowers its Price Target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and Maintains a Buy Rating - Insider Monkey
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail
TriSalus Life Sciences Signals Confident Growth Path - TipRanks
11 Fastest Growing Penny Stocks to Buy Right Now - Insider Monkey
TLSIW Stock Price, News & Analysis - Stock Titan
Research Analysts Issue Forecasts for TLSI Q1 Earnings - MarketBeat
Canaccord Genuity Group Has Lowered Expectations for TriSalus Life Sciences (NASDAQ:TLSI) Stock Price - Defense World
TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Canaccord Genuity Group Issues Pessimistic Forecast for TriSalus Life Sciences (NASDAQ:TLSI) Stock Price - MarketBeat
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings By Investing.com - Investing.com South Africa
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings - Investing.com
TriSalus Life Sciences Q4 Earnings Call Highlights - Yahoo Finance
Boston Scientific to buy Penumbra in $14.5 billion deal - AOL.com
TriSalus Life Sciences reaffirms $60M–$62M revenue guidance for 2026 while expanding PEDD portfolio - MSN
Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise - Investing.com
TriSalus (TLSI) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise By Investing.com - Investing.com South Africa
TriSalus Life Sciences (NASDAQ:TLSI) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
TriSalus Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance - Bluefield Daily Telegraph
Earnings Summary: TriSalus Life Sciences Q4 - Benzinga
Cancer treatment tech firm TriSalus lifts 2025 sales 53%, aims $60-62M in 2026 - Stock Titan
TLSI SEC FilingsTriSalus Life Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Exploring TriSalus Life Sciences's Earnings Expectations - Benzinga
1.53%
자본화:
|
볼륨(24시간):